Product Licensing
European patent for Vaxfectin adjuvant granted to biopharmaceutical company
Published in Cancer Weekly, August 31st, 2004
Specific claims include compositions and methods for gene-based vaccination using immunogens or immunogen-encoding polynucleotides plus the Vaxfectin cationic lipid/co-lipid formulation.
The new patent is titled, "Adjuvant Compositions for Enhancing Immune Responses to Polynucleotide-Based Vaccines." It and other patents held by Vical are based on the company's discovery that administering polynucleotides, such as DNA or RNA, to tissues, without the use of viral delivery vehicles, may result in expression of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-08-31)
More Articles from Cancer Weekly
- Breast Cancer Vaccine
Tamoxifen and soluble tumor-associated antigens suppress breast cancer - Cancer Therapy
Pironetin selectively targets alpha-tubulin Lys352 - Cancer Vaccine
Mesothelin is new target for immunotherapy of mesotheliomas - Lung Cancer
Protein expression profiles useful in diagnosis - Oral Cancer
Oral cancer epidemic expected due to use of betel quid substitutes - Acute Myeloid Leukemia
AML-associated mutant inhibits differentiation of myeloid/erythroid stem cells - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
